Aim: The objective of this meta-analysis is to assess the data regarding changes in herbal cannabis potency over time (from 1970 to 2009).
INTRODUCTION
The cannabis market is the largest illicit drug market in terms of the global spread of cultivation, volume of production and number of consumers [1] .
There is great interest in the subject, sometimes linked with apprehension about increasing drug potency and its effects on human health, as revealed by newspapers [2] [3] [4] [5] , government reports [6, 7] , and scientific publications [8] [9] [10] [11] despite the scarce availability of reliable data; existing information on cannabis is fragmented, non-standardized and not always based on scientific evidence.
Published data concerning the diffusion of high potency cannabis varieties and the level of increase in potency are poor worldwide; further, new and successful cultivation methods -which allow selection, cloning and the stimulation of the best plant varieties -exist in the drug market alongside imported, traditional and low psychotropic subspecies [12] . There is variability within and between publications with regards to the sourcing, sampling and analytical approaches to herbal cannabis.
*Address correspondence to this author at the Istituto di Medicina Legale, Università Cattolica del S Cuore, largo F. Vito, 1 00168 Roma, Italy; Tel: +39 335 7011646; E-mail: f.cascini@rm.unicatt.it Herbal cannabis consists of the dried flowering, fruiting tops and leaves of the cannabis plant [13] . The aim of this meta-analysis is to summarize published results concerning the -9-tetrahydrocannabinol (THC) content of cannabis 1 in order to determine the temporal trend in mean THC content over the period 1970 -2009 .
METHODS
The systematic review and meta-analysis shown here are new on this topic, even if a narrative review of nine publications has been published previously [14] .
The sources used for guidance were the Cochrane Handbook [15] and the PRISMA guidelines [16] . 1 Study selection -This process (see the flow diagram in Fig. 1 ) was performed independently but uniformly by two authors, and included screening, determination of eligibility and inclusion of the eligible studies in the systematic review, and meta-analysis of the results on THC content in herbal cannabis samples.
We considered papers and not monographic scientific publications, rejecting all studies that were not focused on the subject of this review, such as those concerning the toxic effects of cannabinoids on humans and animals, synthetic cannabinoids and their pharmacological properties, genetic features of the cannabis plant, social issues and drug policy on cannabis.
We also excluded studies that completely or partially lacked clear data, such as articles that reported the THC content not clearly attributable to the herbal form of cannabis (including experimental cultivation) or that presented results together as a range of different concentrations or periods of time.
No divergent opinions in including or excluding studies were encountered between the reviewers, resulting in 21 studies that were eligible for the systematic review and metaanalysis.
Data extraction -This process was performed by two reviewers independently, resolving disagreement by discussion. Repetitions of data from serial publications were rejected, retaining the last update. Two authors were contacted for further information. All the eligible, included studies were written in the English language.
The following information was extracted from each included article and summarized:
• characteristics of the publication such as authors, study design, year and type of publication, first and second objectives, results and conclusion of the report; Meta and Trend Analysis -We meta-analyzed the results of the included studies by year to take into account the evident temporal trend in the mean % of THC. Given the heterogeneity between studies we adopted a random effects model [17] . We used the I 2 statistic to quantify the degree of heterogeneity among studies [18] . I 2 values of 50% or more indicate a substantial level of heterogeneity. Meta-regression using year as the covariate was performed to assess whether a temporal trend could explain the heterogeneity. To quantify the trend a Poisson regression was performed.
RESULTS AND DISCUSSION
All the included studies shown in the table below ( Table 1) were written in English and presented data on the THC content found in herbal cannabis samples in different years, depending on the date of the study.
Most were for an isolated geographic area and period of time and do not describe relevant information about the features (i.e. conservation status and age of the sample) of the analyzed herbal cannabis samples. The percentage of studies reporting the relevant sample details is shown in the bar chart (Fig. 2) that portrays, for example: 13% of the included studies specify the origin of the sample, 8% do not; 11% indicates the mode of sample acquisition, 10% do not.
For published evidence on the temporal trend in potency, we carried out a meta-analysis of the extracted herbal cannabis data from studies in which the standard deviation around the mean THC value per year was available. Metaanalysis was performed by year on 75 total mean THC observations from 1970 to 2009 using the random effect model. Meta-regression was performed on the same dataset, using year as the covariate.
The results revealed great variability within studies (I 2 = 99.91%) and a significant association (from the metaregression) (p value < 0.0001) between the mean THC in herbal cannabis and year (coef. 0.214; 95% CI = 0.163-0.266). A summary of the results from the meta-analysis and relative 95% CI per year are shown in Table 2 and Fig. (3) .
The combined data from the 21 included studies indicated an increasing temporal trend in potency (Fig. 4) ; the Poisson regression suggested an average increase in the mean THC value of 4.694% (95% CI 3.129-6.283). Of course, this is just an indication of the overall increase, but it is clear (from Fig. 4 ) that this rise in mean THC seems to have been more rapid in the last decade.
Analysis of the trend (Tables 3 and 4; Fig. 4) according to geographical zone indicated a smaller increase in Europe (2.799%, 95% CI 1.157-4.467; significant at p = 0.001) compared to the rest of the world, almost totally represented by the U.S. (5.279%, 95% CI 3.590-6.996), but this may reflect the fact that the data from Europe started with a higher mean THC.
The European studies indicated a very high mean THC level in recent years with little variability around this mean, especially in The Netherlands; the cannabis potency phenomenon was, on the other hand, characterized by minor fluctuations and relative stability from 1975 to 1989 in other European countries such as Great Britain and Ireland; data from Greece and Denmark, although scarce, revealed a constantly low mean THC value while Italy, particularly the northern part, showed a clear increasing temporal trend.
No other information concerning Europe was obtained from the publications fulfilling the eligibility criteria for the present review; it must also be noted that the cannabis reports on governmental websites are the responsibility of single research groups in each country.
With regard to the rest of the countries (particularly U.S.A.), an evident rise in the mean THC content in herbal cannabis seizure samples from 1997 to 2009, with large variability around this mean value, was reported by the Mississippi University Project [40] .
The results of this systematic review suggest that the herbal cannabis market is changing worldwide towards an increasing level of THC content. Further, this increase is not constant and does not exceed 5% globally. According to some [41] it would be right to admit a doubling of potency over the years, possibly due to the increased availability of intensively grown indoor herbal cannabis, but not that cannabis is 25 times stronger than it was a decade ago [4] .
On the other hand it should be considered that data from the included studies could present an underestimation of the true mean THC value of commercial herbal cannabis because of the freshness and age of samples from harvesting, their composition before chemical analysis, and the sampling method for the analysis. It is actually well known that the THC content in cannabis can vary in relation to environmental factors such as light, temperature and the humidity during plant growth and sample storage, as well as being influenced by genetic features [42] [43] [44] [45] . differences between laboratories, even though the analytical techniques are the same worldwide, involving gas or liquid chromatography eventually coupled with mass spectrometry [46, 47] . Fig. (3) . Per-year meta-analysis graph showing the mean THC value with 95% CI. Fig. (4) . Time trend of the mean THC value for all samples and disaggregated by zone. To overcome the methodological limits for cannabis samples, recommendations for the standardization of analytical procedures have recently been proposed by United Nations Office on Drugs and Crime [48] . We also hope for an alignment of the interested nations with regular monitoring of the cannabis market to enable constant tracking of the THC temporal trend in accordance with validated guidelines on sample classification, storage, sampling and analytical methods, and the data required from the analyses. Systematic reviews and the meta-analysis of data from heterogeneous case series studies can be complex. On the other hand they are useful to outline the shape of a phenomenon, as in the case of cannabis, concerning an increasing temporal trend in the potency of this drug.
Future Research Questions:
• The herbal cannabis market is changing toward an increasing tetrahydrocannabinol (THC) content, although published international data concerning the diffusion of such potent varieties and the level of increase in potency are poor: existing information on cannabis is fragmented, non-standardized and not always based on scientific evidence.
• Continuous, worldwide tracking of herbal cannabis's THC level in accordance with validated guidelines on sampling, sample classification, storage and analytical methods, and the data obtained from analysis, could allow countries interested in the monitoring of the cannabis market to pool their resources to greater effect.
• Clear information about drug potency could be useful for societal and political decisions relating to public health (i.e. health educational programmes for youth, prevention campaigns, prohibition measurements) and also for judicial verdicts concerning illegal traffic and for criminalistics.
• Scientific investigations on cannabis through genetic and chemical analyses could be undertaken to describe and explain the natural and/or artificial mechanisms behind the potency increase with the aim of controlling the drug market more effectively.
